Lymphoma Hub
@lymphomahub
A global education platform providing clinical updates on a range of lymphoma subtypes and chronic lymphocytic leukemia (#CLL) linktr.ee/Lymphoma #lymsm
ID: 1582593798
http://www.lymphomahub.com 10-07-2013 08:56:22
10,10K Tweet
9,9K Followers
2,2K Following
CONGRESS|#EHA2023 Matthew Frank Stanford Medicine discusses the safety and efficacy of CD22 CART therapy in pts with LBCL who have relapsed after CD19 CART therapy. The ORR and CR rates were 68% and 53%, respectively #lymphoma #lymsm #medicalcongress
